Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Stopped Scientific rationale is deemed obsolete. Funders lost interest in the trial.

Conditions

• Brain Metastasis
• Breast Cancer
• Non Small Cell Lung Cancer

Interventions

• DRUG: Cabazitaxel
• PROCEDURE: Contrast-enhanced whole brain MRI

Sponsor

Jules Bordet Institute

Collaborators

• [object Object]